HCM
SRRA

Hayman Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Hayman Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,555
Closed -$8.66M – 11
2015
Q3 		$8.66M Buy
+10,555
New +$11.9M 4% 9

Other funds holding SRRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hayman Capital Management's SRRA Position: Q4 2015 in Review

Hayman Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2015, closing a stake of 10,555 shares — an estimated $8.66M sold.

Hayman Capital Management first reported a position in SRRA in Q3 2015 and held it in 1 quarter. The position peaked at $8.66M in Q3 2015. 47 funds tracked by Wall St. Rank hold SRRA as of Q4 2015.

  • Hayman Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Hayman Capital Management sold 10,555 Sierra Oncology, Inc. Common Stock shares in Q4 2015, an estimated $8.66M.
  • Hayman Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Hayman Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $8.66M in Q3 2015.
  • 47 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2015.

Based on Hayman Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.